Prostate cancer waiting times could be radically cut by an 'extremely encouraging' 20 minute test, scientists have revealed.

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...

The largest documented outbreak of blastomycosis in the United States was reported at a paper mill in Michigan in 2022-2023.

DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated by its ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

A sick pet is a pet parent’s most dreaded experience. While many illnesses can be treated with medication, some require more ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...

National Resilience, Inc. (Resilience), a technology-driven biomanufacturing leader dedicated to broadening access to complex medicines, today announced the expansion of its collaboration with Parvus ...

An ultrasound test that takes less than 20 minutes could improve the accuracy of prostate cancer diagnosis, scientists say.

Microbix has been a leading producer of purified and inactivated Antigens from native (natural) bacterial and viral organisms for more than three decades. It supplies these critical biological ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...